Home › Trial NCT04999384
First in Human, Dose Escalation Study of AN4005
- Trial IDNCT04999384
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorAdlai Nortye Biopharma Co., Ltd.
- Enrollment31
- Start date2021-09-27
- ConditionsAdvanced Solid Tumor · Advanced Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.